Physician profile
David Bradley Anders
NPI 1023545910
$2,916.87
in general payments reported to CMS, 2019-2025
15 companies · $818 in 2025
The $818 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $23.92 · 2021: $134 · 2022: $469 · 2023: $375 · 2024: $568 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395 · Entertainment: $367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.51 |
| Entertainment | $367.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $842.31 | 2019-2025 | Precision 7, Total30, Precision 1 |
| Optos, INC. | $736.90 | 2019-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $267.99 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $262.74 | 2023-2025 | Cequa |
| Glaukos Corporation | $134.99 | 2022 | |
| Rxsight INC | $118.80 | 2024 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Coopervision INC. | $117.77 | 2024 | Clariti Contact Lens |
| Mallinckrodt Hospital Products INC. | $102.90 | 2025 | Acthar |
| Johnson & Johnson Vision Care, INC. | $72.46 | 2019 | |
| Alimera Sciences, INC. | $61.87 | 2019 | |
| Dompe US, INC. | $57.21 | 2025 | Oxervate |
| Apellis Pharmaceuticals, INC. | $51.57 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $43.19 | 2024 | Xdemvy |
| Astellas Pharma US INC | $23.97 | 2024 | Izervay |
| Thea Pharma INC. | $22.20 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Anders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.